A challenge to the field of pharmacogenomics has been applying genetic tests meaningfully in the clinic. At The Corpus Callosum, a clinician blogs about the recent news that Neuromark has developed a genetic test to identify patients with increased susceptibility for suicide after starting taking an antidepressant.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.